(Q40603276)

22 September 2017

1 reference

title

Clinical comparison of adult and pediatric NeuroAIDS. (English)

1 reference

22 September 2017

Mintz M

1

1 reference

22 September 2017

1 January 1994

1 reference

Advances in neuroimmunology

22 September 2017

1 reference

22 September 2017

4

1 reference

22 September 2017

207-221

1 reference

22 September 2017

3

1 reference

A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. The Terry Beirn Community Programs for Clinical Research on AIDS.

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Acoustically evoked event-related potentials in HIV-associated dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Pediatric HIV infection: a neuropsychological and educational challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Clinical pharmacology of 2',3'-dideoxyinosine in human immunodeficiency virus-infected children.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Vaccines in AIDS. Present state of knowledge

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Pediatric acquired immunodeficiency syndrome. Neurologic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Reconstruction and future trends of the AIDS epidemic in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Effect of continuous-infusion zidovudine therapy on neuropsychologic functioning in children with symptomatic human immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Virological markers in the cerebrospinal fluid from HIV-1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Dideoxyinosine in Children with Symptomatic Human Immunodeficiency Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

HIV-1-associated psychotic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Management of Neurologic Opportunistic Disorders in Human Immunodeficiency Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neuromuscular diseases associated with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Mitochondrial myopathy caused by long-term zidovudine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Wernicke's encephalopathy in AIDS patient treated with zidovudine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Incidence of AIDS dementia in a two-year follow-up of AIDS and ARC patients on an initial phase II AZT placebo-controlled study: San Diego cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Lymphocyte subsets in healthy children during the first 5 years of life

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Spinal cord pathology in pediatric acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Maternal-fetal transmission of human immunodeficiency virus: a review of possible routes and cellular mechanisms of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

The Edinburgh cohort of HIV-positive drug users: pattern of cognitive impairment in relation to progression of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Expression of human immunodeficiency virus in cerebrospinal fluid of children with progressive encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neurologic signs in young children with human immunodeficiency virus infection. The European Collaborative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neuronal loss in the frontal cortex in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Multifactorial nature of human immunodeficiency virus disease: implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

AIDS dementia complex complicated by cytomegalovirus encephalopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Brainstem auditory evoked responses in infants and children with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Immunological Markers in the Cerebrospinal Fluid of HIV-1-Infected Children

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Massive neuronal destruction in human immunodeficiency virus (HIV) encephalitis. A clinico-pathological study of a pediatric case

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Intrathecal IgG synthesis and specificity of oligoclonal IgG in patients infected with HIV-1 do not correlate with CNS disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

The neuropsychiatry of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neuropathological evidence that zidovudine reduces incidence of HIV infection of brain

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Effect of zidovudine on cerebrospinal fluid in patients with HIV infection and acute neurological disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Acquired immunodeficiency syndrome in Romania

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Human immunodeficiency virus-associated meningitis. Clinical course and correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

A hospital-based prospective study of perinatal infection with human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neurological and neuropshychological manifestations of HIV-1 infection: Association with AIDS-related complex but not asymptomatic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Epidemiology of Human Immunodeficiency Virus Infection and the Neurologic Complications of the Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Epidemiology of human immunodeficiency virus encephalopathy in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Manic syndrome in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Pharmacokinetics of 2',3'-dideoxycytidine in patients with AIDS and related disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Human immunodeficiency virus-infected macrophages, gp120, and N-methyl-D-aspartate receptor-mediated neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

A model-based estimate of the mean incubation period for AIDS in homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Manic syndrome early and late in the course of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Detection of HIV in fetal central nervous system tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Selective neuronal vulnerability in HIV encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Spectrum of human immunodeficiency virus-associated neocortical damage

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Tumour necrosis factor (TNF-alpha) and neurological disorders in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1-infected individuals: results from the multicenter AIDS Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neuropathological changes in early HIV-1 dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Proton MR Spectroscopy of the Brain in AIDS Dementia Complex

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neurologic Manifestations of Pediatric Acquired Immunodeficiency Syndrome: Clinical Features and Therapeutic Approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Declining incidence of AIDS dementia complex after introduction of zidovudine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Dementia associated with human immunodeficiency virus: subcortical or cortical?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Only temporary improvement in impaired neuropsychological function in AIDS patients treated with zidovudine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Human Immunodeficiency Virus-Related Cognitive Impairment and the Acquired Immunodeficiency Syndrome Dementia Complex

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Antiretroviral therapy for adult HIV-infected patients. Recommendations from a state-of-the-art conference. National Institute of Allergy and Infectious Diseases State-of-the-Art Panel on Anti-Retroviral Therapy for Adult HIV-Infected Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Low Education as a Possible Risk Factor for Cognitive Abnormalities in HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Central Nervous System Involvement of Children with Hiv Nfection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Wernicke's encephalopathy in two patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Survival in children with perinatally acquired human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

HIV-1 infection: no evidence of cognitive decline during the asymptomatic stages. The Multicenter AIDS Cohort Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Pathologic features of AIDS encephalopathy in children: evidence for LAV/HTLV-III infection of brain

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Spinal cord disease in children with HIV-1 infection: a combined molecular biological and neuropathological study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Pathology of HIV-1 infection of the central nervous system. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neuromuscular Complications of Human Immunodeficiency Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Prednisone improves human immunodeficiency virus encephalopathy in children

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Acquired immunodeficiency syndrome. Cerebrospinal fluid findings in patients before and during long-term oral zidovudine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Electroencephalogram and HIV infection: a prospective study in 100 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

HIV-1 sensitivity to zidovudine and clinical outcome in children

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Cerebral metabolic dysfunction in AIDS: findings in a sample with and without dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Progressive multifocal leukoencephalopathy in pediatric acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Intrathecal synthesis of anti-HIV IgG: correlation with increasing duration of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Myopathy in human immunodeficiency virus-infected children receiving long-term zidovudine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neocortical damage during HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Relationship of cerebrospinal fluid immune activation associated factors to HIV encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Seizures in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

Neurobehavioral outcomes in diseases of childhood: Individual change models for pediatric human immunodeficiency viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980259-7

7 January 2021

10.1016/S0960-5428(06)80259-7

Identifiers

DOI

1 reference

22 September 2017

1 reference

PubMed ID

7874389